The Life Sciences Law Firm Index: Patent Category Update
Which law firms were at the top of our patent category through Q3 2017?
Which law firms were at the top of our patent category through Q3 2017?
The Life Sciences Law Firm Index identifies the most active and relevant firms for life science companies.
Adoption of Chrometa represents more than a technological upgrade; it reflects a professional philosophy that values accuracy, transparency, and efficiency.
Leaders of WilmerHale’s life sciences practice share trends they see regarding acquisitions and initial public offerings.
What does the market for life sciences M&A look like right now?
What does the market for life sciences companies look like right now?
Experts offer their takes on the developing dealmaking environment in the early days of the Trump Administration.
This Pro Bono Week, get inspired to give back with PLI’s Pursuing Justice: The Pro Bono Files, a one-of-a-kind podcast hosted by Alicia Aiken.
Which law firms were at the top of our patent category through Q1 2016?
As states began to jump onto the pharmaceutical regulation bandwagon around the turn of the century, Porzio Bromberg & Newman brought John Ohoro on to help clients sift through the growing maze of rules and regulations across the U.S.
Not too long ago, it didn’t take much for someone with an idea for a new medical device to rake in the early-stage funding.
These are tough times in the biotech and pharmaceutical industries: Funding is drying up, investors are fleeing the space, the IPO door is pretty firmly shut, valuations are dropping, activists are lurking and the headlines are anything but kind. But when the going gets tough, the tough consider strategic alternatives...
As of October 2025, U.S. Citizenship and Immigration Services requires electronic payments for filing fees. Learn key updates, exemptions, and how firms can prepare.